Table 1.
Microarray analysis to compare the gene expression profile between cells expressing either ApoAI or ApoLinkerP144
| Abbreviation | Gene name | No categories | Fold change |
|---|---|---|---|
| Col18a1 | Collagen, type XVIII, alpha 1 | 6 | −1.511 |
| Hgf | Hepatocyte growth factor | 9 | −1.681 |
| Mmp9 | Matrix metallopeptidase 9 | 8 | −2.734 |
| Itga1 | Integrin, alpha 1 | 6 | −1.067 |
| Foxo3 | Forkhead box O3 | 3 | −1.058 |
| Vegfc | Vascular endothelial growth factor C | 3 | −1.519 |
| Cox2 | Cyclooxygenase 2 | 6 | −1.145 |
| Mmp2 | Matrix metallopeptidase 2 | 4 | −2.057 |
| Nfkbia | Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha | 4 | −1.215 |
| Fas | TNF receptor superfamily, member 6 | 4 | −2.651 |
| C3 | Complement component 3 | 3 | −2.398 |
| Nos2 | Nitric oxide synthase 2, inducible | 4 | −3.024 |
| Sema4d | Semaphorin 4D | 6 | 1.258 |
| Tgfbr2 | Transforming growth factor, beta receptor II | 7 | 1.293 |
| Thbs1 | Thrombospondin 1 | 7 | 2.269 |
| Wisp1 | Wnt1 inducible signaling pathway protein 1 | 5 | 1.207 |
| Tlr4 | Toll-like receptor 4 | 4 | 1.413 |
A selection of upregulated and downregulated genes involved in several functional categories and the fold change are shown